Publications by authors named "Amel Zertal"

Article Synopsis
  • Multiple sclerosis (MS) is a debilitating disease affecting over 90,000 Canadians, and current treatments only offer limited relief; many patients turn to cannabis for symptom management despite the lack of solid scientific backing.
  • This clinical trial seeks to evaluate the effectiveness of various doses of cannabinoids (THC and CBD), both individually and in combination, for alleviating spasticity in MS patients, comparing results against a placebo group.
  • The study will involve 250 participants and utilize a double-blind, randomized design, measuring outcomes such as self-reported spasticity, pain, and quality of life over a period of four weeks, with potential for an additional 12-week treatment phase for those who respond well.
View Article and Find Full Text PDF

Context: Studies generally focus on one type of chronic condition and the effect of medical cannabis (MC) on symptoms; little is known about the perceptions and engagement of patients living with chronic conditions regarding the use of MC.

Objectives: This scoping review aims to explore: (1) what are the dimensions addressed in studies on MC that deal with patients' perceptions of MC? and (2) how have patients been engaged in developing these studies and their methodologies? Through these objectives, we have identified areas for improving future research.

Methods: We searched five databases and applied exclusion criteria to select relevant articles.

View Article and Find Full Text PDF

After a lull of >20 years, Algeria experienced a cholera outbreak in 2018 that included 291 suspected cases. We found that outbreak isolates were Vibrio cholerae O1 serotype Ogawa from seventh pandemic El Tor sublineage AFR14, which corresponds to a new introduction of cholera into Africa from South Asia.

View Article and Find Full Text PDF

Background: Despite a global increase in contraception use, its prevalence remains low in low- and middle-income countries. One strategy to improve uptake and use of contraception, as an essential complement to policies and supply-side interventions, is demand generation. Demand generation interventions have reportedly produced positive effects on uptake and use of family planning services, but the evidence base remains poorly documented.

View Article and Find Full Text PDF